The pro-inflammatory cytokine TNFα is another candidate as a potential biomarker as it is increased in CSF levels in AD patients (Llano et al., 2012) and is associated with increased cognitive decline in AD patients with systemic infection (Holmes et al., 2009). Here, TNF is linked to Alzheimer disease.